Company: INGN
Filing Date: 2025-05-19
Form Type: 8-K
Source: 0000950170-25-074437
Chunk: 3

Company: Inogen Inc
Filing Date: 2025-05-19
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit      Description                                                                                                            
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
     10.1      Amended and Restated 2023 Equity Incentive Plan                                                                        
     10.2      Form of Stock Option Agreement under the Amended and Restated 2023 Equity Incentive Plan                               
     10.3      Form of Restricted Stock Unit Agreement (Time-Based) under the Amended and Restated 2023 Equity Incentive Plan         
     10.4      Form of Restricted Stock Unit Agreement (Performance-Based) under the Amended and Restated 2023 Equity Incentive Plan  
      104      The cover page of this Current Report on Form 8-K, formatted in inline XBRL.                                           

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                                        INOGEN, INC.                                  
  Date:      May 19, 2025      By:      /s/ Michael Bourque                           
                                        Michael Bourque